Drug-induced gingival hyperplasia: An in vitro study using amlodipine and human gingival fibroblasts

Dorina Lauritano, Marcella Martinelli, Alessandro Baj, Giada Beltramini, Valentina Candotto, Francesco Ruggiero, Annalisa Palmieri

Research output: Contribution to journalArticle


Gingival overgrowth is a serious side effect that accompanies the use of amlodipine. Several conflicting theories have been proposed to explain the fibroblast's function in gingival overgrowth. To determine whether amlodipine alters the inflammatory responses, we investigated its effects on gingival fibroblast gene expression as compared with untreated cells. Fragments of gingival tissue of healthy volunteers (11 years old boy, 68 years old woman, and 20 years old men) were collected during operation. Gene expression of 29 genes was investigated in gingival fibroblast cell culture treated with amlodipine, compared with untreated cells. Among the studied genes, only 15 (CCL1, CCL2D, CCL5, CCL8, CXCL5, CXCL10, CCR1, CCR10, IL1A, IL1B, IL5, IL7, IL8, SPP1, and TNFSF10) were significantly deregulated. In particular, the most evident overexpressed genes in treated cells were CCR10 and IL1A. These results seem to indicate a possible role of amlodipine in the inflammatory response of treated human gingival fibroblasts.

Original languageEnglish
Article number2058738419827746
JournalInternational Journal of Immunopathology and Pharmacology
Publication statusPublished - Jan 1 2019


  • amlodipine
  • fibroblast
  • gene expression
  • gingival overgrowth

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Fingerprint Dive into the research topics of 'Drug-induced gingival hyperplasia: An in vitro study using amlodipine and human gingival fibroblasts'. Together they form a unique fingerprint.

  • Cite this